Daiichi Sankyo
FDA Grants AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Its Fifth Breakthrough Label
2022-04-28
Daiichi Sankyo to Launch mRNA COVID-19 Vaccine in 2022, Shionogi Presents Clinical Results of COVID-19 Oral Drug
2021-10-22
AstraZeneca, Daiichi Sankyo’s Potential Blockbuster Bags Second US Approval, This Time for Gastric Cancer
2021-01-22
Daiichi Sankyo Collaboration Marks ViGeneron’s Second Gene Therapy Deal in a Single Month
2021-01-19
ASCO 2020: AstraZeneca and Daiichi Sankyo’s Enhertu Impresses with Benefits in Lung, Stomach and Colorectal Cancer Trials
2020-06-05